CLU and liver disorder: One of the consistenly and significantly changed core fucosylated glycopeptides is the biantennary and triantennary LANTQGEDQYYLR peptide of clusterin (Fig. 4) which was previously described in liver disease by our group33 and by others (panel of analytes in patent US20090208926A1 ).